-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Ok7D6qPD7ep0JkR9zL9PQqtXgOxvbvOEhBOfW+krb06UP7P+bRsT6nURjzx18C2+
 ivIpsrOYx5xoniQ0Mp0U6Q==

<SEC-DOCUMENT>0001010549-09-000439.txt : 20090616
<SEC-HEADER>0001010549-09-000439.hdr.sgml : 20090616
<ACCEPTANCE-DATETIME>20090616093023
ACCESSION NUMBER:		0001010549-09-000439
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20090615
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20090616
DATE AS OF CHANGE:		20090616

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WOUND MANAGEMENT TECHNOLOGIES, INC.
		CENTRAL INDEX KEY:			0000714256
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				592220004
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-11808
		FILM NUMBER:		09893227

	BUSINESS ADDRESS:	
		STREET 1:		777 MAIN STREET
		STREET 2:		SUITE 3100
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102
		BUSINESS PHONE:		817-820-7080

	MAIL ADDRESS:	
		STREET 1:		777 MAIN STREET
		STREET 2:		SUITE 3100
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MB SOFTWARE CORP
		DATE OF NAME CHANGE:	19960805

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INAV TRAVEL CORPORATION
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TWISTEE TREAT CORP
		DATE OF NAME CHANGE:	19910220
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>wound8k061509.htm
<TEXT>
<html>
    <head>
        <title></title>
    </head>

    <body style="FONT-SIZE: 12pt; FONT-FAMILY: 'TIMES NEW ROMAN'">
        <p></p>

        <p style="MARGIN-TOP: 0pt; FONT-SIZE: 12pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0in; TEXT-INDENT: 0px" align="center"><b>SECURITIES AND EXCHANGE COMMISSION</b> <!-- CONTINUOUS SECTION BREAK --></p>

        <p></p>

        <p style="MARGIN-TOP: 0pt; FONT-SIZE: 12pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0in; TEXT-INDENT: 0px" align="center">Washington, D.C. 20549<br>
        &nbsp;<br>
        &nbsp;</p>

        <p style="MARGIN-TOP: 0pt; FONT-SIZE: 12pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0in; TEXT-INDENT: 0px" align="center"><b>FORM 8-K<br>
        CURRENT REPORT<br>
        &nbsp;</b></p>

        <p style="MARGIN-TOP: 0pt; FONT-SIZE: 12pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0in; TEXT-INDENT: 0px" align="center"><font size="2">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        Date of Report (Date of earliest event reported): <u>June 15, 2009</u></font></p>

        <p></p>

        <p style="MARGIN-TOP: 0pt; FONT-SIZE: 12pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0in; TEXT-INDENT: 0px" align="center"><font size="2"><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wound Management Technologies, Inc.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> <br>
        (Exact name of registrant as specified in its charter)</font></p>

        <p style="MARGIN-TOP: 0pt; FONT-SIZE: 12pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0in; TEXT-INDENT: 0px" align="center">&nbsp;</p>

        <p style="MARGIN-TOP: 0pt; FONT-SIZE: 12pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0in; TEXT-INDENT: 0px"></p>

        <table cellspacing="0" cellpadding="0" width="100%" border="0">
            <tr>
                <td width="90">
                </td>

                <td width="264" colspan="1">
                    <p align="center"><u><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Texas&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u></p>
                </td>

                <td width="240">
                    <p align="center"><u><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0-11808&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u></p>
                </td>

                <td width="253">
                    <p align="center"><u><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;59-2219994&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u></p>
                </td>

                <td width="106">
                </td>
            </tr>

            <tr>
                <td width="90">
                </td>

                <td width="264">
                    <p align="center"><font size="2">(State or other jurisdiction</font></p>
                </td>

                <td width="240">
                    <p align="center"><font size="2">(Commission File</font></p>
                </td>

                <td width="253">
                    <p align="center"><font size="2">(IRS Employer</font></p>
                </td>

                <td width="106">
                </td>
            </tr>

            <tr>
                <td width="90">
                </td>

                <td width="264">
                    <p align="center"><font size="2">incorporation)</font></p>
                </td>

                <td width="240">
                    <p align="center"><font size="2">Number)</font></p>
                </td>

                <td width="253">
                    <p align="center"><font size="2">Identification No.)</font></p>
                </td>

                <td width="106">
                </td>
            </tr>

            <tr>
                <td width="90">
                </td>

                <td width="264">
                </td>

                <td width="240"><font size="2">&nbsp;</font></td>

                <td width="253">
                </td>

                <td width="106">
                </td>
            </tr>

            <tr>
                <td width="90">
                </td>

                <td width="264">
                </td>

                <td width="240"><font size="2">&nbsp;</font></td>

                <td width="253">
                </td>

                <td width="106">
                </td>
            </tr>

            <tr>
                <td width="90">
                </td>

                <td colspan="2">
                    <p align="center"><u><font size="2">&nbsp;777 Main Street, Suite 3100, Fort Worth, Texas</font></u></p>
                </td>

                <td width="253"><u><font size="2">&nbsp;&nbsp;&nbsp;&nbsp; 76102&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></u></td>

                <td width="106">
                </td>
            </tr>

            <tr>
                <td width="90">
                </td>

                <td colspan="2">
                    <p align="center"><font size="2">(Address of principal executive offices)&nbsp;</font></p>
                </td>

                <td width="253"><font size="2">(Zip Code)&nbsp;</font></td>

                <td width="106">
                </td>
            </tr>

            <tr>
                <td width="90">
                </td>

                <td width="264">
                </td>

                <td width="240"><font size="2">&nbsp;</font></td>

                <td width="253">
                </td>

                <td width="106">
                </td>
            </tr>

            <tr>
                <td width="90">
                </td>

                <td colspan="3">
                    <p align="center"><font size="2">Registrant&rsquo;s telephone number, including area code </font><u><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;817-820-7080</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>
                </td>

                <td width="106">
                </td>
            </tr>
        </table>

        <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; EEPStyleName: Para Just 10pt TNR" align="justify">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

        <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"></p>

        <table cellspacing="0" cellpadding="0" width="100%" border="0">
            <tr valign="bottom">
                <td align="left" width="2%"><font face="Times New Roman" size="2">[_]</font></td>

                <td align="left" width="1%"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="1%"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="94%"><font face="Times New Roman" size="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></td>

                <td align="left" width="1%"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="1%"><font face="Times New Roman" size="2">&nbsp;</font></td>
            </tr>

            <tr>
                <td align="left">
                </td>

                <td align="left">
                </td>

                <td align="left">
                </td>

                <td align="left">&nbsp;</td>

                <td align="left">
                </td>

                <td align="left">
                </td>
            </tr>

            <tr valign="bottom">
                <td align="left"><font face="Times New Roman" size="2">[_]</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left"><font face="Times New Roman" size="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>
            </tr>

            <tr>
                <td align="left">
                </td>

                <td align="left">
                </td>

                <td align="left">
                </td>

                <td align="left">&nbsp;</td>

                <td align="left">
                </td>

                <td align="left">
                </td>
            </tr>

            <tr valign="bottom">
                <td align="left"><font face="Times New Roman" size="2">[_]</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left"><font face="Times New Roman" size="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>
            </tr>

            <tr>
                <td align="left">
                </td>

                <td align="left">
                </td>

                <td align="left">
                </td>

                <td align="left">&nbsp;</td>

                <td align="left">
                </td>

                <td align="left">
                </td>
            </tr>

            <tr valign="bottom">
                <td align="left"><font face="Times New Roman" size="2">[_]</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left"><font face="Times New Roman" size="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>
            </tr>
        </table>
        <br>
        <br>


        <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" align="center"><br>
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a name="PAGENUM">1</a></p>
        <!-- PAGE BREAK  -->

        <div title="EE+ Page Break" style="FONT-SIZE: 1pt; PAGE-BREAK-AFTER: always; WIDTH: 100%; HEIGHT: 1px">
            <hr width="100%" color="#000000" noshade size="2">
        </div>

        <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; EEPStyleName: Para Just 10pt TNR" align="justify"><b>Item 8.01 Other Events.</b></p>

        <p style="FONT-SIZE: 10pt; TEXT-INDENT: 0.5in; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; EEPStyleName: Para Just 10pt TNR First Line Ind .5 Inch" align="left">Wound Management Technologies, Inc., announced today that it has reached an agreement in principle to acquire BioPharma Management Technologies, Inc., a privately held biotechnology company with a platform of proprietary and patented technologies for topical pain management and resorbable orthoses. The
        transaction would be structured as a share exchange pursuant to which BioPharma would become a wholly owned subsidiary of Wound Management in exchange for 5,000,000 shares of Wound Management common stock. The transaction is subject to certain contingencies, including a complete legal, financial and technical review of BioPharma by Wound Management.</p>

        <p></p>

        <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; EEPStyleName: Para Just 10pt TNR" align="justify"><b>Item 9.01 Financial Statements and Exhibits</b></p>

        <p style="FONT-SIZE: 10pt; TEXT-INDENT: 0.5in; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; EEPStyleName: Para Just 10pt TNR First Line Ind .5 Inch" align="justify">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.</p>

        <blockquote dir="ltr" style="MARGIN-RIGHT: 0px">
            <p style="FONT-SIZE: 10pt; TEXT-INDENT: 0.5in; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; EEPStyleName: Para Just 10pt TNR First Line Ind .5 Inch" align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Press Release dated June 15, 2009</p>
        </blockquote>

        <p></p>

        <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" align="center"><b>SIGNATURES</b></p>

        <p></p>

        <p style="FONT-SIZE: 10pt; TEXT-INDENT: 0.5in; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; EEPStyleName: Para Just 10pt TNR First Line Ind .5 Inch" align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

        <p align="justify"></p>

        <table cellspacing="0" cellpadding="0" width="100%" border="0">
            <tr valign="bottom">
                <td align="left" width="30%">
                </td>

                <td align="left" width="1%"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="199"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="439"><font face="Times New Roman" size="2">Wound Management Technologies, Inc.</font></td>

                <td align="left" width="1%"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="1%"><font face="Times New Roman" size="2">&nbsp;</font></td>
            </tr>

            <tr valign="bottom">
                <td align="left"><font face="Times New Roman" size="2">Date: June 15, 2009</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="199"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td width="439">
                </td>

                <td>
                </td>

                <td>
                </td>
            </tr>

            <tr valign="bottom">
                <td align="left">
                </td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="199"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="439"><font face="Times New Roman" size="2"><u>/s/Scott A. Haire</u></font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>
            </tr>

            <tr valign="bottom">
                <td align="left">
                </td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="199"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="439"><font face="Times New Roman" size="2">Scott A. Haire, Chairman of the Board,</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>
            </tr>

            <tr valign="bottom">
                <td align="left">
                </td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="199"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="439"><font face="Times New Roman" size="2">Chief Executive Officer</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>
            </tr>

            <tr valign="bottom">
                <td align="left">
                </td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="199"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="439"><font face="Times New Roman" size="2">And President (Principal Financial</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>
            </tr>

            <tr valign="bottom">
                <td align="left">
                </td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="199"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left" width="439"><font face="Times New Roman" size="2">Officer)</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>

                <td align="left"><font face="Times New Roman" size="2">&nbsp;</font></td>
            </tr>
        </table>
        <br>
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>
        <br>


        <p></p>

        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0in; TEXT-INDENT: 0px">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0in; TEXT-INDENT: 0px"></p>

        <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0in; TEXT-INDENT: 0px" align="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a name="PAGENUM"><font size="2">2</font></a></p>
    </body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>wound8kex991061509.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html>
    <head>
        <title></title>
    </head>

    <body style="FONT-SIZE: 12pt; FONT-FAMILY: 'TIMES NEW ROMAN'">
        <p style="MARGIN-TOP: 0pt; FONT-SIZE: 12pt; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 0in; TEXT-INDENT: 0px" align="left"></p>

        <table cellspacing="0" cellpadding="0" width="100%" border="0">
            <tr>
                <td width="532" rowspan="2"><font size="6">NEWS BULLETIN</font></td>

                <td width="38"><font size="2">RE:</font></td>

                <td width="364"><font size="2">&nbsp;Wound Management Technologies, Inc.</font></td>

                <td width="2%">
                </td>
            </tr>

            <tr>
                <td width="38">
                </td>

                <td width="364"><font size="2">777 Main Street</font></td>

                <td width="2%">
                </td>
            </tr>

            <tr>
                <td width="532">
                </td>

                <td width="38">
                </td>

                <td width="364"><font size="2">Suite 3100</font></td>

                <td width="2%">
                </td>
            </tr>

            <tr>
                <td width="532">
                </td>

                <td width="38">
                </td>

                <td width="364"><font size="2">Fort Worth, Texas 76102</font></td>

                <td width="2%">
                </td>
            </tr>

            <tr>
                <td width="532">
                </td>

                <td width="38">
                </td>

                <td width="364">
                </td>

                <td width="2%">
                </td>
            </tr>

            <tr>
                <td width="532"><font size="2"><strong>From:</strong> <i>Wound Management Technologies, Inc.</i></font></td>

                <td width="38">
                </td>

                <td width="364">
                </td>

                <td width="2%">
                </td>
            </tr>

            <tr>
                <td style="BORDER-BOTTOM: black 1px solid" width="532"><font size="2">&nbsp;</font></td>

                <td style="BORDER-BOTTOM: black 1px solid" width="38"><font size="2">&nbsp;</font></td>

                <td style="BORDER-BOTTOM: black 1px solid" width="364"><font size="2">&nbsp;</font></td>

                <td style="BORDER-BOTTOM: black 1px solid" width="2%"><font size="2">&nbsp;</font></td>
            </tr>

            <tr>
                <td width="532"><font size="2">For Further Information:</font></td>

                <td width="38">
                </td>

                <td width="364">
                </td>

                <td width="2%">
                </td>
            </tr>

            <tr>
                <td style="BORDER-BOTTOM: black 1px solid" width="532"><font size="2">Product Information&nbsp;</font></td>

                <td style="BORDER-BOTTOM: black 1px solid" width="38"><font size="2">&nbsp;</font></td>

                <td style="BORDER-BOTTOM: black 1px solid" width="364"><font size="2">Shareholder Relations</font></td>

                <td style="BORDER-BOTTOM: black 1px solid" width="2%"><font size="2">&nbsp;</font></td>
            </tr>

            <tr>
                <td width="532"><font size="2">Cathy Bradshaw</font></td>

                <td width="38">
                </td>

                <td width="364"><font size="2">Lucy Singleton</font></td>

                <td width="2%">
                </td>
            </tr>

            <tr>
                <td width="532"><font size="2">President</font></td>

                <td width="38">
                </td>

                <td width="364"><font size="2">Secretary</font></td>

                <td width="2%">
                </td>
            </tr>

            <tr>
                <td width="532"><font size="2">954-315-9242</font></td>

                <td width="38">
                </td>

                <td width="364"><font size="2">817-820-7080</font>&nbsp;</td>

                <td width="2%">
                </td>
            </tr>

            <tr>
                <td style="BORDER-BOTTOM: black 1px solid" width="532">&nbsp;</td>

                <td style="BORDER-BOTTOM: black 1px solid" width="38">&nbsp;</td>

                <td style="BORDER-BOTTOM: black 1px solid" width="364">&nbsp;</td>

                <td style="BORDER-BOTTOM: black 1px solid" width="2%">&nbsp;</td>
            </tr>

            <tr>
                <td width="532"><u><font size="2">FOR IMMEDIATE RELEASE</font></u></td>

                <td width="38">
                </td>

                <td width="364">
                </td>

                <td width="2%">
                </td>
            </tr>

            <tr>
                <td width="532"><font size="2">June 16, 2009</font></td>

                <td width="38">
                </td>

                <td width="364">
                </td>

                <td width="2%">
                </td>
            </tr>
        </table>

        <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; EEPStyleName: Para Just 10pt TNR" align="left">Fort Worth, Texas &ndash; (BUSINESS WIRE) &ndash; June 16, 2009 -Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (WNDM.OB), announced today that it has reached an agreement in principle to acquire BioPharma Management Technologies, Inc., a privately held biotechnology company with a platform of proprietary and
        patented technologies for topical pain management and resorbable orthoses.&nbsp; The transaction would be structured as a share exchange pursuant to which BioPharma would become a wholly owned subsidiary of Wound Management in exchange for 5,000,000 shares of Wound Management common stock.&nbsp; The transaction is subject to certain contingencies, including a complete legal, financial and technical review of BioPharma by Wound Management.<br>
        &nbsp;<br>
        &ldquo;We believe that BioPharma&rsquo;s proprietary technologies and its future products will be complementary to CellerateRx and will provide a broad application across several of the medical markets that we currently serve,&rdquo; said Mr. Scott Haire, Wound Management&rsquo;s Chief Executive Officer.&nbsp; &ldquo;We have been focused on bringing the science and technology of CellerateRx to the market over the past year, and we believe that the additional science and technology
        behind BioPharma would solidify Wound Management as a leading provider of wound care products.&rdquo;</p>

        <p></p>

        <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; EEPStyleName: Para Just 10pt TNR" align="left"><b>About Wound Management Technologies, Inc.:</b></p>

        <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; EEPStyleName: Para Just 10pt TNR" align="left">Wound Management Technologies, Inc. (OTCBB:WNDM), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company
        please visit the Company's Website at www.Celleraterx.com .</p>

        <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; EEPStyleName: Para Just 10pt TNR" align="left"><b>About BioPharma Management Technologies, Inc.</b> <b>:</b></p>

        <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; EEPStyleName: Para Just 10pt TNR" align="left">BioPharma is a biotechnology company that recently launched the development proprietary technologies and associated product applications for topical pain management and resorbable orthoses.</p>

        <p style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; EEPStyleName: Para Just 10pt TNR" align="left"><b>"Safe</b> Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation
        Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic
        conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.<br>
        <br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;<br>
        &nbsp;</p>

        <p></p>
    </body>
</html>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
